- Drugs
- Monday, 04 May 2020
Pharmaceutics International Selected as A Winner of Two GH&P Awards
Pharmaceutics International, Inc. (Pii), a US-based Contract Development and Manufacturing Organization (CDMO) today announced it has won the 2020 CDMO Leadership Award and was named the Most Innovative Company in Dosage Solutions by Global Health & Pharma Magazine.
"We are honored to be recognized in these two categories. Pii has an extensive range of technologies, skilled personnel and Pharmaceutics Know-How™, to enable the rapid development and reliable production of high-quality sterile and oral dosage forms. It is extremely gratifying to have our innovation, accomplishments and commitment to partners and patients acknowledged," said Dr. Kurt R. Nielsen, Pii's President and CEO.
According to GH&P, "Biotechnology is a huge, varied and ever-growing industry. Operating and succeeding in such an environment which, in many ways, demands excellence at every turn is - it goes without saying - incredibly difficult, yet there are businesses that have learned to thrive under such conditions. To harness innovation and deliver results, driving the greater industry onwards." Jazmin Collins, GH&P Awards Coordinator, commented "Regardless of their size or location, we honor companies from across this vibrant and talented sector."
Related Industry Updates
Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company
May 19, 2020
Ion Channel Modulators Market - Segmentation, Manufacturing Cost Analysis Including Key Raw Materials, Price Trend, Key Suppliers and Forecast 2027
Mar 09, 2021
DisposeRx Adds New Community Outreach Partners to Stop Prescription Drug Abuse
Jun 10, 2020
Autoimmune Diseases: Prevalence, Diagnosis, and Treatment Advances
Feb 10, 2026
Innovent and Lilly Collaborate to Advance Novel Medicines
Feb 09, 2026
Cold, Cough and Sore Throat Remedies Market Report Offers Intelligence And Forecast Till 2027
Nov 26, 2020
Pfizer to Acquire Metsera with Next-Generation Obesity Portfolio
Feb 24, 2026